Results 31 to 40 of about 2,359,169 (353)

Association of radiation dose intensity with overall survival in patients with distant metastases

Cancer Medicine, 2021
Background Patients with metastatic cancer referred to radiation oncology have diverse prognoses and there is significant interest in personalizing treatment.
Johnny Kao, Mark K. Farrugia, Samantha Frontario, Amanda Zucker, Emily Copel, John Loscalzo, Ashish Sangal, Boramir Darakchiev, Anurag Singh, Symeon Missios   +9 more
doaj   +1 more source

Dimethyl fumarate in the management of multiple sclerosis: Appropriate patient selection and special considerations [PDF]

, 2016
Delayed-release dimethyl fumarate (DMF), also known as gastroresistant DMF, is the most recently approved oral disease-modifying treatment (DMT) for relapsing multiple sclerosis. Two randomized clinical trials (Determination of the Efficacy and Safety of
Pontecorvo, Simona, Prosperini, Luca
core   +1 more source

Liver Transplantation in Adults [PDF]

, 1982
Human liver transplantation has been possible since 1967. We report our experience in 32 adult patients who received liver transplants at the University of Pittsburgh over a 16‐month period.
Dugas, M, Gavaler, JS, Iwatsuki, S, Schade, RR, Shaw Jr ., BW, Starzl, TE, Van Thiel, DH   +6 more
core   +1 more source

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

Frontiers in Oncology, 2023
BackgroundThe role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is evolving.
D. Doppenberg, D. Doppenberg, D. Doppenberg, F. J. Lagerwaard, F. J. Lagerwaard, S. van Dieren, M. R. Meijerink, M. R. Meijerink, J. J. van der Vliet, J. J. van der Vliet, J. J. van der Vliet, M. G. Besselink, M. G. Besselink, G. van Tienhoven, G. van Tienhoven, E. Versteijne, E. Versteijne, B. J. Slotman, B. J. Slotman, J. W. Wilmink, J. W. Wilmink, G. Kazemier, G. Kazemier, A. M. E. Bruynzeel, A. M. E. Bruynzeel   +24 more
doaj   +1 more source

Waiting Lists and Patient Selection [PDF]

Journal of Economics & Management Strategy, 2005
We develop a positive model of waiting lists for public hospitals when physicians are able to divert patients from the public to the private sector. Public treatment is free but rationed, i.e., only cases meeting some medical criteria are admitted. Private treatment has no waiting time but entails payment of a fee.
Pedro Pita Barros, Pau Olivella
openaire   +5 more sources

Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?

Livers, 2022
Patients with advanced hepatocellular carcinoma (HCC) have a very limited survival rate even after the recent inclusion of kinase inhibitors or immune checkpoint inhibitors in the therapeutic armamentarium. A significant problem with the current proposed
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki   +2 more
doaj   +1 more source

Radiogenomics: the utility in patient selection [PDF]

Translational Cancer Research, 2017
The goal of radiation therapy (RT) is to deliver the therapeutic dose to target tissues minimizing the risks of normal tissue complication. Nowadays, technological advances in radiation delivery and the introduction of particle therapies have strongly limited the amount of dose distributed to normal tissues and enhanced the tumor killing capacity. Here,
Giusi Irma Forte, Luigi Minafra, Valentina Bravatà, Francesco Paolo Cammarata, Debora Lamia, Pietro Pisciotta, Giuseppe Antonio Pablo Cirrone, Giacomo Cuttone, Maria Carla Gilardi, Giorgio Russo   +9 more
openaire   +4 more sources

Prediction of Tissue Damage Using a User-Independent Machine Learning Algorithm vs. Tmax Threshold Maps

Clinical and Translational Neuroscience, 2021
(1) Background: To test the accuracy of a fully automated stroke tissue estimation algorithm (FASTER) to predict final lesion volumes in an independent dataset in patients with acute stroke; (2) Methods: Tissue-at-risk prediction was performed in 31 ...
Arsany Hakim, Benjamin Messerli, Raphael Meier, Tomas Dobrocky, Sebastian Bellwald, Simon Jung, Richard McKinley, Roland Wiest   +7 more
doaj   +1 more source

FoxO1 signaling in B cell malignancies and its therapeutic targeting

FEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac, Petra Pavelkova, Laura Ondrisova, Marek Mraz   +3 more
wiley   +1 more source

Low‐dose hilar and mediastinal stereotactic body radiation therapy for non‐small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment

Thoracic Cancer, 2020
Background This study reports the outcomes of a single institutional experience treating non‐small cell lung cancer (NSCLC) involving the pulmonary hilum with low‐dose stereotactic body radiation therapy (SBRT).
Roman O. Kowalchuk, Michael R. Waters, Martin Richardson, Kelly Spencer, James M. Larner, Charles R. Kersh   +5 more
doaj   +1 more source